International HIV Treatment as Prevention Workshop

International HIV Treatment as Prevention Workshop

Political Segment

What new targets for treatment? Which aim? Which resources?

The International HIV Treatment as Prevention Workshop brings together academic, policy, industry, and community representatives to review and discuss research and policy progress in the field of HIV treatment as prevention. This Davos-style roundtable session will bring together key national decision-makers and pivotal international partners to explore the importance of new treatment targets, drawing on best practices and country-led examples.

This is an open educational event sponsored by the BC Centre for Excellence in HIV/AIDS and is a special session of the HIV/ARV Update. This event is in lieu of the Spring 2014 Update. Lunch will be provided on site.

Registration is now closed. On-site registration is not available.


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below